Kim MS, Kim WJ, Khera AV, Kim JY, Yon DK, Lee SW, et al. Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies. Eur Heart J. 2021;42:3388–403.
Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766–81.
Rothman KJ. BMI-related errors in the measurement of obesity. Int J Obes. 2008;32:S56–9.
Gelber RP, Gaziano JM, Orav EJ, Manson JAE, Buring JE, Kurth T. Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol. 2008;52:605–15.
Woolcott OO, Bergman RN. Relative fat mass (RFM) as a new estimator of whole-body fat percentage ─ a cross-sectional study in American adult individuals. Sci Rep. 2018;8:1–11.
Yu P, Huang T, Hu S, Yu X. Predictive value of relative fat mass algorithm for incident hypertension: a 6-year prospective study in Chinese population. BMJ Open. 2020;10:e038420.
Suthahar N, Meems LMG, Withaar C, Gorter TM, Kieneker LM, Gansevoort RT, et al. Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND. Sci Rep. 2022;12:1–9.
Woolcott OO, Bergman RN. Defining cutoffs to diagnose obesity using the relative fat mass (RFM): Association with mortality in NHANES 1999–2014. Int J Obes. 2020;44:1301–10.
Andreasson A, Carlsson AC, Önnerhag K, Hagström H. Predictive capacity for mortality and severe liver disease of the relative fat mass algorithm. Clin Gastroenterol Hepatol. 2019;17:2619–20.
Suthahar N, Wang K, Zwartkruis VW, Bakker SJL, Inzucchi SE, Meems LMG, et al. Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population. Eur J Intern Med. 2023;109:73–8.
Scholtens S, Smidt N, Swertz MA, Bakker SJL, Dotinga A, Vonk JM, et al. Cohort profile: LifeLines, a three-generation cohort study and biobank. Int J Epidemiol. 2015;44:1172–80.
Zwartkruis VW, Groenewegen A, Rutten FH, Hollander M, Hoes AW, van der Ende MY, et al. Proactive screening for symptoms: a simple method to improve early detection of unrecognized cardiovascular disease in primary care. Results from the Lifelines cohort study. Prev Med. 2020;138:106143.
World Health Organisation (WHO). Waist circumference and waist–hip ratio. Report of a WHO Expert Consultation. Geneva, 8–11 December 2008
Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–35.
Welch Allyn. MEANS ECG Physicians’ Manual for Welch Allyn CP Series Electrocardiographs MEANS Physicians Manual Caution. 2016. www.welchallyn.com.
van der Ende MY, Siland JE, Snieder H, van der Harst P, Rienstra M. Population-based values and abnormalities of the electrocardiogram in the general Dutch population: the LifeLines cohort study. Clin Cardiol. 2017;40:865–72.
van der Ende MY, Hartman MHT, Schurer RAJ, van der Werf HW, Lipsic E, Snieder H, et al. Prevalence of electrocardiographic unrecognized myocardial infarction and its association with mortality. Int J Cardiol. 2017;243:34–9.
van der Ende MY, Hartman MHT, Hagemeijer Y, Meems LMG, de Vries HS, Stolk RP, et al. The LifeLines cohort study: prevalence and treatment of cardiovascular disease and risk factors. Int J Cardiol. 2017;228:495–500.
Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003.
Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body mass index, waist circumference and waist: hip ratio as predictors of cardiovascular riska review of the literature. Eur J Clin Nutr. 2010;64:16–22.
Dunkley AJ, Stone MA, Patel N, Davies MJ, Khunti K. Waist circumference measurement: knowledge, attitudes and barriers in patients and practitioners in a multi-ethnic population. Fam Pract. 2009;26:365–71.
Senkus KE, Crowe-White KM, Locher JL, Ard JD. Relative fat mass assessment estimates changes in adiposity among female older adults with obesity after a 12-month exercise and diet intervention. Ann Med. 2022;54:1160–6.
Groenewegen A, Zwartkruis VW, Rienstra M, Hollander M, Koffijberg H, Cramer MJM, et al. Improving early diagnosis of cardiovascular disease in patients with type 2 diabetes and COPD: protocol of the RED-CVD cluster randomised diagnostic trial. BMJ Open. 2021;11:e046330.
Han TS, Tajar A, Lean MEJ. Obesity and weight management in the elderly. Br Med Bull. 2011;97:169–96.
Wagenaar CA, Dekker LH, Navis GJ. Prevalence of sarcopenic obesity and sarcopenic overweight in the general population: the lifelines cohort study. Clin Nutr. 2021;40:4422–9.
Klijs B, Scholtens S, Mandemakers JJ, Snieder H, Stolk RP, Smidt N. Representativeness of the LifeLines cohort study. PLoS ONE. 2015;10:1–12.
Aune D, Sen A, Norat T, Janszky I, Romundstad P, Tonstad S, et al. Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies. Circulation. 2016;133:639–49.
Aune D, Snekvik I, Schlesinger S, Norat T, Riboli E, Vatten LJ. Body mass index, abdominal fatness, weight gain and the risk of psoriasis: a systematic review and dose–response meta-analysis of prospective studies. Eur J Epidemiol. 2018;33:1163–78.
Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004;57:1096–103.
Englert H, Müller-Nordhorn J, Seewald S, Sonntag F, Völler H, Meyer-Sabellek W, et al. Is patient self-report an adequate tool for monitoring cardiovascular conditions in patients with hypercholesterolemia? J Public Health. 2010;32:387–94.
